RxDoctor Payments Data

David Cutler, MD

Family Medicine · Santa Monica, CANPI 1255368338

Payments from drug & device makers

$8,678in general payments, 2019–2025

Across 104 payments — averaging $83.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$6K
  • Amgen$1K
  • Novo Nordisk$363
  • Lilly USA, LLC$264
  • AstraZeneca$252
  • Gilead$217
  • plus $565 from 13 others

What the payments were for

  • Consulting fees$5,60065%
  • Food & beverage$3,05735%
  • Education$210%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,678 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$126,496
Medicare patients
284
Services billed
1,945

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide26$55,086
EliquisApixaban37$40,839
JardianceEmpagliflozin17$21,519
OzempicSemaglutide12$13,012
Atorvastatin Calcium359$3,946
Qvar RedihalerBeclomethasone Dipropionate12$3,711
Rosuvastatin Calcium146$3,319
Tolterodine Tartrate ErTolterodine Tartrate18$3,106
SynthroidLevothyroxine Sodium43$2,980
Arnuity ElliptaFluticasone Furoate11$2,553
Levothyroxine Sodium151$2,101
Losartan Potassium127$1,958
ValacyclovirValacyclovir Hcl42$1,939
Tamsulosin Hcl116$1,925
Amlodipine Besylate174$1,365

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$363$68,09838 claims
PfizerEliquis$5,841$40,83937 claims
GSKArnuity Ellipta$51$2,55311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,533 family medicine providers in California.

Other family medicine in Santa Monica

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →